Subscribe

Spotlight -

Community/Retail|

Pharmacy Technician|

Erica Wegrzyn, BA, BS, PharmD

Articles by Erica Wegrzyn, BA, BS, PharmD

Treatment of Neuropathic Pain

ByJeffrey Fudin, PharmD, DAAPM, FASHP, FCCP,Jeffrey Bettinger, PharmD Candidate,Erica Wegrzyn, BA, BS, PharmD

April 17th 2017

Chronic pain has been defined by the International Association for the Study of Pain as pain that persists beyond the normal tissue healing time of 3 months, and it may be classified into 3 distinct categories: nociceptive, neuropathic, and a mixture of the two.

Latest Updated Articles

Study: How Individual Carbohydrate Responses Reveal Metabolic Health and Potential Biomarkers
Published: June 12th 2025 | Updated: June 16th 2025
Department of Health and Human Services Reconstitutes ACIP, Removing 17 Sitting Members
Published: June 10th 2025 | Updated: June 12th 2025
NLA 2025: Managing Omega-3 Therapy With Statins, PCSK9 Inhibitors for Cardiovascular Care
Published: June 2nd 2025 | Updated: June 11th 2025
ASCO 2025: Zongertinib Shows Strong Potential in HER2-Mutant NSCLC Treatment Landscape
Published: June 3rd 2025 | Updated: June 11th 2025
Emerging Data: Impacts of ROCKstar and AGAVE-201
Published: May 30th 2025 | Updated: June 5th 2025
Measles Cases Climb to 800 in United States as Outbreak Spreads Across Borders
Published: April 18th 2025 | Updated: April 21st 2025

Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights

IMS 2025: Quadruplet Regimens Enhance Depth of Response in Multiple Myeloma

Updated IMWG Guidelines Spotlight MRD, Functional Imaging, and Light Chain Assays in Multiple Myeloma

Elranatamab Plus Daratumumab and Lenalidomide Yields Durable Responses, Manageable Safety

IMS 2025: Future Directions for CAR T Therapy in Relapsed and Refractory Multiple Myeloma

Effectively Managing Immunizations in the Long-Term Care Setting

© 2025 MJH Life Sciences^®

All rights reserved.